ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Pulmonary Disease

Top Pulmonary Disease Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
AZIZ RAHMAN MD

Pulmonary Disease

31,147

$3M

799
543 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 59%

$96
Average prescription price

Avg: $140

BRAHMA GUPTA M.D.

Pulmonary Disease

15,788

$990K

307
224 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 59%

$63
Average prescription price

Avg: $140

ANGELO SOYANGCO MD

Pulmonary Disease

14,496

$869K

682
579 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 59%

$60
Average prescription price

Avg: $140

JOHN KELSEY M.D.

Pulmonary Disease

12,818

$376K

626
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 59%

$29
Average prescription price

Avg: $140

KISHORBHAI PATEL M.D.

Pulmonary Disease

7,632

$692K

575
482 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 59%

$91
Average prescription price

Avg: $140

USMAN CHEEMA MD

Pulmonary Disease

7,305

$476K

544
449 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 59%

$65
Average prescription price

Avg: $140

KAILASH SHARMA M.D.

Pulmonary Disease

6,126

$479K

344
271 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 59%

$78
Average prescription price

Avg: $140

MURRAY SALZMAN M.D.

Pulmonary Disease

6,070

$343K

163
163 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 59%

$57
Average prescription price

Avg: $140

JARMO ITKONEN MD

Pulmonary Disease

5,547

$340K

254
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 59%

$61
Average prescription price

Avg: $140

MAURY TOPOLOSKY M.D.

Pulmonary Disease

5,069

$372K

254
162 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 59%

$73
Average prescription price

Avg: $140

RAJU ABRAHAM M.D.

Pulmonary Disease

4,424

$700K

341
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 59%

$158
Average prescription price

Avg: $140

FREDRIC KULLBERG M.D.

Pulmonary Disease

4,263

$746K

525
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 59%

$175
Average prescription price

Avg: $140

LANIE EAGLETON M.D.

Pulmonary Disease

4,220

$352K

211
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 59%

$83
Average prescription price

Avg: $140

KRISHNA SUNKARA MD

Pulmonary Disease

4,186

$282K

208
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 59%

$67
Average prescription price

Avg: $140

KIM TREVIRANUS M.D.

Pulmonary Disease

4,047

$433K

340
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 59%

$107
Average prescription price

Avg: $140

JAMES VEST MD

Pulmonary Disease

3,993

$271K

372
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 59%

$68
Average prescription price

Avg: $140

MANOOCHER NASSERY M.D.

Pulmonary Disease

3,935

$301K

202
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 59%

$77
Average prescription price

Avg: $140

PHILLIP COZZI MD

Pulmonary Disease

3,755

$324K

319
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 59%

$86
Average prescription price

Avg: $140

JEREMIAH CRABB M.D.

Pulmonary Disease

3,653

$763K

420
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 59%

$209
Average prescription price

Avg: $140

ADA ARIAS M.D.

Pulmonary Disease

3,448

$362K

230
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 59%

$105
Average prescription price

Avg: $140

AMJAD KHAN MD

Pulmonary Disease

3,277

$200K

257
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

24%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 59%

$61
Average prescription price

Avg: $140

MANZOOR SHAH MD

Pulmonary Disease

3,268

$209K

205
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 59%

$64
Average prescription price

Avg: $140

JOANNE KIRBY MD

Pulmonary Disease

3,264

$254K

245
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 59%

$78
Average prescription price

Avg: $140

RICKY JOHNSON M.D.

Pulmonary Disease

3,067

$141K

109
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 59%

$46
Average prescription price

Avg: $140

MICHAEL HENIFF M.D.

Pulmonary Disease

3,061

$587K

283
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 59%

$192
Average prescription price

Avg: $140

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank